Hebei Medical University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1894-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hebmu.edu.cn
Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 48
- Registration Number
- NCT02509806
- Locations
- 🇨🇳
Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT02380131
- Locations
- 🇨🇳
Department of Internal Medicine-Oncology, Shijiazhuang, Hebei, China
Long-term Prednisone Use for End-stage Heart Failure
- First Posted Date
- 2014-11-04
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 90
- Registration Number
- NCT02282683
- Locations
- 🇨🇳
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Prednisone for Heart Failure Patients With Hyperuricemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-02
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 205
- Registration Number
- NCT02129764
Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT01962376
- Locations
- 🇨🇳
Department of Internal Medicine-Oncology, Shijiazhuang, Hebei, China
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT01962233
- Locations
- 🇨🇳
the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 169
- Registration Number
- NCT01962246
- Locations
- 🇨🇳
Department of General Surgery, Shijiazhuang, Hebei, China
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT01946048
- Locations
- 🇨🇳
the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2013-11-15
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT01942915
- Locations
- 🇨🇳
the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2013-09-09
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT01937416
- Locations
- 🇨🇳
the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
© Copyright 2024. All Rights Reserved by MedPath